Zobrazeno 21 - 30
of 8 152
pro vyhledávání: ''
Autor:
Kjetil Retterstøl, Anders Hovland, Christ Berge, Kirsten B. Holven, Jeanine E. Roeters van Lennep, Martin Prøven Bogsrud, Tone Svilaas, Marianne Klevmoen, Elisabeth Kleivhaug Vesterbekkmo
Publikováno v:
Atherosclerosis, 335, 8-15. Elsevier Ireland Ltd
Atherosclerosis
Atherosclerosis
Background and aims: Women with heterozygous familial hypercholesterolemia (FH) are recommended to initiate statin treatment at the same age as men (from 8 to 10 years of age). However, statins are contraindicated when pregnancy is planned, during pr
Autor:
Hirohisa Endo, Hiroki Nishiyama, Kikuo Isoda, Hiroyuki Daida, Tomotaka Dohi, Norihito Takahashi, Yoshiteru Kato, Yuichi Chikata, Shinichiro Doi, Tatsuya Fukase, Katsumi Miyauchi, Iwao Okai, Hiroshi Iwata, Shinya Okazaki, Tohru Minamino
Publikováno v:
Atherosclerosis. 333:9-15
Little is known about the long-term impact of apolipoprotein E (apoE) on residual cardiovascular risk in patients with chronic coronary syndrome (CCS) receiving statin treatment.A total of 1109 consecutive patients (mean age, 67 ± 10 years; 83% men)
Autor:
Olavi Ukkola, Antti M. Kiviniemi, Karri Parkkila, Y. Antero Kesäniemi, Juha S. Perkiömäki, Mikko P. Tulppo
Publikováno v:
Atherosclerosis. 330:36-42
Background and aims: Both carotid intima-media thickness (IMT) and arterial plaques have been shown to predict future CV events. Since there are no previous studies on the subject, our objective was to compare carotid IMT and the length of plaques in
Publikováno v:
Atherosclerosis. 331:1-5
Hypertension increases healthcare costs, but the impact of cardiorespiratory fitness (CRF) on these costs is unknown. This study explored the association between healthcare costs and CRF among hypertensive and normotensive men.We studied 9794 male su
Autor:
Konstantinos N. Syrigos, Garyphallia Poulakou, Ioannis G. Kyriakoulis, Konstantinos G. Kyriakoulis, Anastasios Kollias, Thomas Nitsotolis, George S. Stergiou
Publikováno v:
Atherosclerosis. 330:114-121
Background and aims Statin therapy is administered to patients with high cardiovascular risk. These patients are also at risk for severe course of coronavirus disease 2019 (COVID-19). Statins exhibit not only cardioprotective but also immunomodulator
Autor:
Liying Zhang, Songcheng Yu, Li Zhang, Lulu Wang, Keliang Fan, Wenqian Huo, Dandan Wei, Pengling Liu, Jian Hou, Tao Jing, Yu Song, Qingqing Xu, Juan Wang, Mian Wang, Xue Liu, Linlin Li, Zhenxing Mao, Xiaotian Liu, Luting Nie, Chongjian Wang
Publikováno v:
Atherosclerosis. 330:14-21
Background and aims We aimed to evaluate the effects of serum testosterone, obesity and their interaction on blood pressure (BP) parameters and hypertension among Chinese rural adults. Methods A total of 6199 adults were recruited from the Henan Rura
Publikováno v:
Atherosclerosis. 328:23-32
Background and aims The thiol transferase glutaredoxin 1 controls redox signaling and cellular functions by regulating the S-glutathionylation status of critical protein thiols. Here we tested the hypothesis that by derepressing the expression of glu
Autor:
Ilona Faber, Andreas Pfeiffer, Sabita S. Soedamah-Muthu, Claudia de Wilde, Julie A. Lovegrove, D. Ian Givens, Yakima D. Vogtschmidt, Anne Raben
Publikováno v:
Atherosclerosis. 328:124-135
Background and aims: Higher protein (HP) diets may lead to lower cardiometabolic risk, compared to lower\ud protein (LP) diets. This systematic review and meta-analysis aims to investigate the effects of HP versus LP diets\ud on cardiometabolic risk
Autor:
Kotb Abbass Metwalley, Magda Farghali Gabri, Hekma Saad Farghaly, Duaa M. Raafat, Magdy Algowhary, Ghada Mohamed Saied
Publikováno v:
Atherosclerosis. 328:38-43
Patients with congenital adrenal hyperplasia (CAH) are at increased risk of cardiometabolic abnormalities. We aimed to evaluate vascular endothelial dysfunction and its association with serum neopterin (NP) levels in CAH patients.The study included 4
Autor:
Norman E. Lepor, Thomas S. Hatsukami, Jie Sun, Niranjan Balu, Chun Yuan, Americo A. Simonini, Daniel S. Hippe, Ilan Kedan, Laurn Contreras, Daniel Isquith, Xue-Qiao Zhao, Gador Canton
Publikováno v:
Atherosclerosis. 327:31-38
Background and aims Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors reduce cardiovascular events, but their effects on atherosclerotic plaque remain elusive. Using serial magnetic resonance imaging (MRI), we studied changes in caroti